Centiva Capital »

ImmunoGen shares owned by Centiva Capital

Quarter-by-quarter ownership of ImmunoGen shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 275k 29.65
2023-06-30 $669k 36k 18.87

More positions owned by Centiva Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Msci Usa Mmentm Put Option (MTUM)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Netflix (NFLX)
Agnc Invt Corp Com reit (AGNC)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Ishares Tr National Mun Etf (MUB)
Meta Platforms Cl A (META)
Annaly Capital Management In Com New (NLY)
Ishares Tr Msci Emg Mkt Etf (EEM)

View all positions for Centiva Capital

Top funds holding ImmunoGen

Wellington Management Company
Healthcare Of Ontario Pension Plan Trust Fund
Alliancebernstein
venBio Select Advisor
Decheng Capital
Hsbc Holdings
PRIMECAP Management Company
Allianz Asset Management
DLD Asset Management
Nicholas Investments Partners
MetLife Investment Advisors
American International
Guggenheim Capital, LLC Managers
Angelo, Gordon & Co
Kellner Capital

View all funds holding ImmunoGen